Kerbert Annarein J C, Gupta Saurabh, Alabsawy Eman, Dobler Iwona, Lønsmann Ida, Hall Andrew, Nielsen Signe Holm, Nielsen Mette J, Gronbaek Henning, Amoros Àlex, Yeung Dave, Macnaughtan Jane, Mookerjee Rajeshwar P, Macdonald Stewart, Andreola Fausto, Moreau Richard, Arroyo Vicente, Angeli Paolo, Leeming Diana J, Treem William, Karsdal Morten A, Jalan Rajiv
Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.
Translational and Biomarker Research, GI-DDU, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
JHEP Rep. 2021 Aug 27;3(6):100355. doi: 10.1016/j.jhepr.2021.100355. eCollection 2021 Dec.
BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) is characterised by organ failure(s), high short-term mortality, and, pathophysiologically, deranged inflammatory responses. The extracellular matrix (ECM) is critically involved in regulating the inflammatory response. This study aimed to determine alterations in biomarkers of ECM turnover in ACLF and their association with inflammation, organ failures, and mortality.
We studied 283 patients with cirrhosis admitted for acute decompensation (AD) with or without ACLF, 64 patients with stable cirrhosis, and 30 healthy controls. A validation cohort (25 ACLF, 9 healthy controls) was included. Plasma PRO-C3, PRO-C4, PRO-C5, PRO-C6, and PRO-C8 ( collagen type III-VI and VIII ) and C4M and C6M ( collagen type IV and VI ) were measured. Immunohistochemistry of PRO-C6 was performed on liver biopsies (AD [n = 7], ACLF [n = 5]). A competing-risk regression analysis was performed to explore the prognostic value of biomarkers of ECM turnover with 28- and 90-day mortality.
PRO-C3 and PRO-C6 were increased in ACLF compared to AD ( = 0.089 and <0.001, respectively), whereas collagen degradation markers C4M and C6M were similar. Both PRO-C3 and PRO-C6 were strongly associated with liver function and inflammatory markers. Only PRO-C6 was associated with extrahepatic organ failures and 28- and 90-day mortality (hazard ratio [HR; on log-scale] 6.168, 95% CI 2.366-16.080, <0.001, and 3.495, 95% CI 1.509-8.093, = 0.003, respectively). These findings were consistent in the validation cohort. High PRO-C6 expression was observed in liver biopsies of patients with ACLF.
This study shows, for the first time, evidence of severe net interstitial collagen deposition in ACLF and makes the novel observation of the association between PRO-C6 and (extrahepatic) organ failures and mortality. Further studies are needed to define the pathogenic significance of these observations.
This study describes a disrupted turnover of collagen type III and VI in Acute-on-chronic liver failure (ACLF). Plasma biomarkers of these collagens (PRO-C3 and PRO-C6) are associated with the severity of liver dysfunction and inflammation. PRO-C6, also known as the hormone endotrophin, has also been found to be associated with multi-organ failure and prognosis in acute decompensation and ACLF.
慢加急性肝衰竭(ACLF)的特征为器官功能衰竭、短期死亡率高,且在病理生理学上存在炎症反应紊乱。细胞外基质(ECM)在调节炎症反应中起关键作用。本研究旨在确定ACLF中ECM周转生物标志物的变化及其与炎症、器官功能衰竭和死亡率的关联。
我们研究了283例因急性失代偿(AD)入院的肝硬化患者,其中有无ACLF患者,64例稳定期肝硬化患者以及30例健康对照。纳入了一个验证队列(25例ACLF患者,9例健康对照)。检测血浆中的PRO-C3、PRO-C4、PRO-C5、PRO-C6和PRO-C8(III-VI型和VIII型胶原)以及C4M和C6M(IV型和VI型胶原)。对肝活检组织(AD [n = 7],ACLF [n = 5])进行PRO-C6免疫组化。进行竞争风险回归分析以探讨ECM周转生物标志物对28天和90天死亡率的预后价值。
与AD相比,ACLF患者的PRO-C3和PRO-C6升高(分别为P = 0.089和P <0.001),而胶原降解标志物C4M和C6M相似。PRO-C3和PRO-C6均与肝功能和炎症标志物密切相关。只有PRO-C6与肝外器官功能衰竭以及28天和90天死亡率相关(风险比[HR;对数尺度]分别为6.168,95% CI 2.366 - 16.080,P <0.001;以及3.495,95% CI 1.509 - 8.093,P = 0.003)。这些发现在验证队列中一致。在ACLF患者的肝活检组织中观察到PRO-C6高表达。
本研究首次显示了ACLF中严重的间质胶原净沉积证据,并首次观察到PRO-C6与(肝外)器官功能衰竭及死亡率之间的关联。需要进一步研究来确定这些观察结果的致病意义。
本研究描述了慢加急性肝衰竭(ACLF)中III型和VI型胶原周转的破坏。这些胶原的血浆生物标志物(PRO-C3和PRO-C6)与肝功能障碍和炎症的严重程度相关。PRO-C6,也称为激素内营养蛋白,还被发现与急性失代偿和ACLF中的多器官衰竭及预后相关。